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Background. There is no agreement among researchers on viable controls for acupuncture treatment, and the assessment of the
effectiveness of blinding and its interpretation is rare. Purpose. To systematically assess the effectiveness of blinding (EOB) in
reported acupuncture trials; to explore results of RCTs using a quantitative measure of EOB. Data Sources. A systematic review
of published sham RCTs that assessed blinding. Study Selection. Five hundred and ninety studies were reviewed, and 54 studies
(4783 subjects) were included. Data Extraction. The number of patients who guessed their treatment identity was extracted from
each study. Variables with possible influence on blinding were identified.Data Synthesis.Theblinding index was calculated for each
study. Based on blinding indexes, studies were congregated into one of the nine blinding scenarios. Individual study characteristics
were explored for potential association with EOB. Limitations. There is a possibility of publication or reporting bias. Conclusions.
The most common scenario was that the subjects believed they received verum acupuncture regardless of the actual treatment
received, and overall the subject blinding in the acupuncture studies was satisfactory, with 61% of study participants maintaining
ideal blinding. Objectively calculated blinding data may offer meaningful and systematic ways to further interpret the findings of
RCTs.
1. Introduction
The presence of a viable control is important for any research
study, allowing for valid comparison to the condition of
interest. Randomized controlled trials (RCTs) are the primary
way that many areas of research examine the comparative
effectiveness of verum and control conditions. Patient blind-
ing in these studies is essential for gathering reliable results
that can be expanded upon. However, blinding success in
nonpharmacologic interventions, such as acupuncture, can
be difficult to assess, and results may not be applicable from
one study to the next, due to differences in control methods
and in how blinding success is determined, if it is considered
at all. The CONSORT 2010 Statement on blinding suggests
that it is important to include how blinding was attempted,
but there is no mention in the statement of how to assess
whether blinding was successful [1]. Without knowing if
the specific nonpharmacologic blinding techniques used are
valid overall, the information collected may or may not be
reliable. We believe it is imperative that blinding success
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be assessed toward better understanding of the reliability of
results.
With respect to acupuncture research specifically, devel-
oping a control procedure that is physiologically inert and
indistinguishable from true treatment has proven to be a
challenge due to the very nature of traditional acupuncture.
It has resulted in a variety of control methods that up
until now have not been compared in terms of blinding
success [2–5]. The traditional techniques of acupuncture
(penetrating needles at acupoints for different organ systems
and deqi) are the verum conditions of most acupuncture
studies. Control conditions include penetrating needles at
“nonpoints” and “wrong points,” commercially-developed
nonpenetrating devices, homemade nonpenetrating needles,
and toothpicks or cocktail sticks [6–9]. “Nonpoints” are
points not used for any purpose in traditional acupunc-
ture. For the “wrong points,” sham acupuncture is done
at points thought to affect a different body system than
the one targeted by the verum condition. However, the
“wrong point” method may cause a physiological effect
similar to that of acupuncture and, therefore, may be more
appropriately considered to be verum than shamacupuncture
[10].
To date, there is no standard or universally accepted
shamprocedure for acupuncture research andno quantitative
comparison of blinding between the above sham methods.
This may contribute to why there is a discrepancy between
the clinically recognized effectiveness of acupuncture and the
relative lack of research supporting it [11]. Methodological
progress for blinding characteristics, including the amount of
disclosure to study participants, the variables to be collected,
the analytic design, and the interpretation strategy, is needed
in validation studies of sham control procedures [12].
The present meta-analysis systematically examines the
status of blinding in sham acupuncture RCTs via a numerical
measure of blinding index. Our primary aim is to empirically
evaluate the validity (via effectiveness of blinding) of sham
control techniques in order to quantitatively assess blinding
across available studies. We hope to determine the reliability
of the results of studies that used different sham techniques,
so that wemay learn which shammethods aremost useful for
future acupuncture research.We also believe that our system-
atic review is just the beginning of increasing the validity of
the assessment of quantitatively assessed blinding practices in
acupuncture research. Our methods can be further extended
as a model to assess other nonpharmacologic treatments’
blinding techniques.
2. Methods
2.1. Data Sources and Searches. PubMed, Embase, and Web
of Knowledge databases were searched for scientific articles
using the keywords “acupuncture,” “sham acupuncture,” or
“sham procedure.” A revised search was also performed
with OvidMedline using the keywords “acupuncture,” “sham
acupuncture,” or “placebo acupuncture.” Eligible studies were
those that were randomized controlled in humans and were
published in English between 1985 and 2011. Our search was
not limited by patient diagnosis or by the part of the body
where acupuncture was administered.
2.2. Study Selection. A study was considered eligible for
initial screening if the authors stated that they evaluated
blinding. One of the authors (Moroz, Freed, or Tiedemann)
determined if the study reported data on effectiveness of
blinding (EOB) by specifically asking participants if they
thought the treatment used verum (V, real needle used or
needle penetrated the skin) or sham (S) needling techniques,
with or without an option to say they did not know (DK).
If the blinding evaluation data was not included or was
unclear, the authors were contacted twice by e-mail and/or
telephone and asked for additional blinding evaluation data
or clarification. Studies whose authors did not respond or
responded but no longer had access to the original data were
excluded. Studies that used a credibility questionnaire, asking
patients to choosewhether or not they had received treatment
based on the principles of Chinese medicine or another
type of acupuncture, were excluded as well. In these studies,
the patients’ ability to distinguish between verum and sham
needling was not directly addressed and the questionnaire
could bemisinterpreted. If EOBwasmeasuredmultiple times
within the same study, the data collected at the end of the
study or the data collected from the insertion (as opposed
to sensation of deqi or needle withdrawal) arm of the study
would be used. In one work that reported results of two
separate studies using different acupuncture points, one on
the patients’ back and the other on the upper extremity, the
blinding index calculations were done independently [58].
2.3. Data Extraction. For the studies that were included in
this meta-analysis, the number of patients who responded as
V, S, or DK was extracted from each trial. Additionally, the
following variables were extracted from each of the included
studies (we hypothesized a priori that thesemay be associated
with EOB): year of publication, subject only or staff and
subject blinding, time of blinding assessment, assessment
of deqi, type of sham control device used, use of penetrat-
ing or nonpenetrating sham control, patient diagnosis, and
number of days without acupuncture experience prior to
participation. Research staffmembers that were blinded were
those involved in data analysis and interpretation, not those
administering acupuncture.
2.4. Data Synthesis andAnalysis. Statistical analyseswere car-
ried out using the blinding index (BI) in order to objectively
assess EOB [63, 64]. Blinding index estimates the degree
of potential unblinding beyond chance for each arm in a
given study by counting the excessive numbers of correct
guesses. Blinding index values are always between −1 and
1, where 1 corresponds to all correct guesses, whereas −1
corresponds to all incorrect or opposite guesses. If 50% of
patient responses are correct and 50% are incorrect, then
BI = 0; this is indicative of random guessing and thus
is an ideal blinding scenario. Another plausible scenario
indicating effective blinding is that patients tend to believe
they received active treatment regardless of actual treatment
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Table 1: Blinding scenarios [13].
Experimental arm
(verum) Control arm (sham)




Random guess Random guess Ideal, possibly most ideal from thescientific or statistical perspective 8 (15)
Random guess Opposite guess Rare 2 (4)
Random guess Unblinded Possibly little treatment effect andcompletely no effect in control arm 3 (6)
Unblinded Unblinded
Possibly problematic. Treatment effect
in experimental arm and no treatment
effect in control arm (e.g., patients
tend to know what to expect)
4 (7)
Unblinded Opposite guess
Ideal (e.g., patients tend to have
wishful thinking, strong placebo effect,
and any treatment administered is
perceived as real treatment)
25 (46)
Unblinded Random guess
Possibly problematic. Treatment effect
in experimental arm and no treatment
effect in control arm (e.g., patients do
not know what to expect in the
absence of treatment)
12 (22)
Opposite guess Opposite guess Rare 0 (0)
Opposite guess Random guess Rare 0 (0)
Opposite guess Unblinded No treatment effect at all; patients mayhave low expectations 0 (0)
106 randomized controlled studies

















56 studies reported to have
evaluated the effectiveness of
blinding to acupuncture treatment
procedures
130 studies reported to have
evaluated the effectiveness of
blinding to acupuncture treatment
procedures








Figure 1: Systematic review search and selection. ∗One article contained two separate studies.
received, which may reflect patients’ wish to receive active
intervention. In this case, blinding index will have a positive
value in the active treatment arm and a negative value in the
sham treatment arm, where this scenario is denoted later as
unblinded/opposite.
Verum and sham acupuncture groups were each assigned
a separate blinding index value. Based on the calculated
blinding index value combinations for the two treatment
arms, nine possible blinding scenarios were proposed
(Table 1). For classification purposes, we decided to consider
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Table 2: Design characteristics that may be associated with blinding, compared by BI values and scenarios.
Study characteristics Number ofstudies BI (V) BI (S)
BI
(|V| − |S|) Blinding scenario
Sample size
𝑁 < 100 43 0.44 −0.19 0.25 Unblinded/random
𝑁 ≥ 100 11 0.28 −0.20 0.08 Unblinded/opposite
Blinding assessed
Immediately 19 0.50 −0.19 0.31 Unblinded/random
Later 35 0.29 −0.20 0.09 Unblinded/opposite
Blinded parties
Subjects 22 0.52 −0.27 0.25 Unblinded/opposite
Subjects + research staff 32 0.26 −0.17 0.09 Unblinded/random
Assessed for sensation of
Deqi 22 0.33 −0.21 0.12 Unblinded/opposite
Puncture 32 0.35 −0.19 0.16 Unblinded/random
Subject’s status
Healthy 12 0.43 −0.06 0.37 Unblinded/random
Symptomatic 42 0.33 −0.22 0.11 Unblinded/opposite
Subject’s acupuncture experience
Näıve 24 0.27 −0.13 0.14 Unblinded/random
Experienced 19 0.32 −0.19 0.13 Unblinded/random
Sham device used
Commercial 22 0.47 −0.32 0.15 Unblinded/opposite
Custom 14 0.48 −0.17 0.31 Unblinded/random
Penetrating 12 0.16 −0.08 0.08 random/random
Toothpick or cocktail stick 6 0.55 −0.33 0.22 Unblinded/opposite
∗Raw data available in Table 4.
BI ≥ 0.2 unblinded; −0.2 < BI < 0.2 random guesses; BI ≤
−0.2 opposite guesses [13, 64, 65]. (Remark: this cutoff value
was based on authors’ consensus and used as a general tool for
classification and explanation; it should not be interpreted as
an absolute indication of blinding effectiveness.)
Individual variables hypothesized to potentially impact
EOB were compared by their average VBI and SBI scores,
weighted by sample size. The weighted averages were used
to determine the overall blinding index scenario for each
variable. Blinding scenarios were also compared to the overall
outcome of each study. Finally, we looked for patterns of
possible association of study design factors with EOB based
on blinding index values and scenarios. The factors included
were based on data extraction criteria, sample size, timing
of blinding assessment, blinded parties, sensation assessed,
subject’s status, subject’s experience, and sham device used.
3. Results
3.1. Data Search. Using our search inclusion criteria, 590
peer reviewed journal articles were found, with 186 of these
reporting blinding data in RCTs. 133 studies were excluded
from the review, most often due to a lack of patient guess of
treatment allocation.One article reported twodistinct studies
that were included separately [58]. Fifty-four studies were
included in our final analysis, with a total of 4783 patients
(Figure 1).
3.2. Blinding Index Calculations. The blinding index values
(point and interval estimates) computed from all 54 studies
can be found in Figure 2. The average weighted blinding
index values for the entire review were 0.34 for verum and
−0.20 for sham groups, respectively. Overall, a correct guess
is quite common in the verum arm, and opposite guess is not
uncommon in the sham arm.
After grouping studies into the nine possible blinding
scenarios based on the blinding index (Table 1), 33 out of
54 (61%) of the studies might be adequately blinded. Of
these, 70% (23/33) had a positive outcome reported overall;
similarly, 62% (13/21) with less ideal blinding had an overall
positive outcome (Table 3). Unblinded/opposite for V, S is
most common, with 46% of the studies belonging to this
scenario, followed by unblinded/random with 22%.
3.3. Design Characteristics and Effectiveness of Blinding. The
variables hypothesized to affect blinding were compared by
their average VBI and SBI values, and blinding scenarios in
Table 2.
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Table 3: Blinding index values computed from 54 studies.
Study 𝑁 VBI VBI 95% CI SBI SBI 95% CI Scenario Study outcome
Assefi et al. 2005 [14] 75 −0.17 −0.49 to 0.15 0.3 0.10 to 0.49 Random/unblinded Negative
Kaptchuk et al. 2008 [15] 148 0.12 −0.07 to 0.31 −0.52 −0.69 to −0.35 Random/opposite Positive
Kennedy et al. 2008 [9] 45 0.18 −0.13 to 0.49 −0.38 −0.70 to −0.05 Random/opposite Positive
Barlas et al. 2006 [6] 48 −0.09 NA −0.06 NA Random/random Positive
Deng et al. 2008 [16] 53 0.08 −0.30 to 0.46 0.19 −0.18 to 0.55 Random/random Negative
Enblom et al. 2008 [7] 80 0.2 0.00 to 0.40 0.1 −0.13 to 0.33 Random/random Positive
Endres et al. 2007 [17] 403 −0.16 −0.35 to 0.03 −0.04 −0.24 to 0.16 Random/random Positive
Haake et al. 2007 [8] 692 −0.01 −0.09 to 0.07 0.11 0.03 to 0.19 Random/random Positive
Harris et al. 2009 [18] 20 0.2 −0.26 to 0.66 −0.2 −0.57 to 0.17 Random/random Positive
Shin et al. 2010 [19] 42 −0.05 −0.35 to 0.18 0.05 −0.23 to 0.33 Random/random Negative
Zaslawski et al. 1997 [20] 64 0.12 −0.37 to 0.13 0.03 −0.28 to 0.21 Random/random Positive
Deng et al. 2007 [21] 67 0 −0.29 to 0.29 0.46 0.17 to 0.75 Random/unblinded Negative
Jubb et al. 2008 [22] 51 0.18 −0.14 to 0.51 0.3 0.03 to 0.56 Random/unblinded Positive
Alecrim-Andrade et al. 2006 [23] 24 0.21 0.11 to 0.33 −0.29 −0.37 to −0.20 Unblinded/opposite Negative
Berman et al. 2004 [24] 283 0.73 0.63 to 0.82 −0.48 −0.61 to −0.35 Unblinded/opposite Positive
Brinkhaus et al. 2006 [25] 205 0.44 0.30 to 0.57 −0.24 −0.42 to −0.05 Unblinded/opposite Positive
Enblom et al. 2011 [26] 190 0.72 0.60 to 0.83 −0.6 −0.74 to −0.46 Unblinded/opposite Positive
Fink et al. 2001 [27] 64 1 NA −0.75 −0.98 to −0.52 Unblinded/opposite Positive
Goddard et al. 2005 [28] 49 0.58 0.26 to 0.91 −0.76 −1.01 to −0.50 Unblinded/opposite Positive
Goldman et al. 2008 [29] 118 0.42 0.24 to 0.60 −0.62 −0.77 to −0.47 Unblinded/opposite Negative
Itoh et al. 2006 [30] 19 0.48 0.14 to 0.81 −0.32 −0.70 to 0.07 Unblinded/opposite Positive
Itoh et al. 2008 [31] 24 0.56 0.01 to 1.10 −0.5 −1.10 to 0.10 Unblinded/opposite Positive
Lee et al. 2008 [32] 89 0.91 0.79 to 1.03 −0.68 −0.90 to −0.47 Unblinded/opposite Positive
Lee et al. 2011 [33] 35 0.23 −0.06 to 0.51 −0.56 −0.80 to −0.31 Unblinded/opposite Positive
Park et al. 2002 [34] 58 0.38 0.20 to 0.56 −0.31 −0.48 to −0.14 Unblinded/opposite Positive
Park et al. 2005 [35] 94 0.47 0.32 to 0.61 −0.31 −0.48 to −0.13 Unblinded/opposite Negative
Shen et al. 2009 [36] 12 0.63 0.24 to 1.01 −0.5 −0.99 to −0.01 Unblinded/opposite Positive
Sherman et al. 2002 [37] 52 0.65 0.34 to 0.96 −0.52 −0.80 to −0.24 Unblinded/opposite Positive
Smith et al. 2007 [38] 27 1 NA −1 NA Unblinded/opposite Positive
So et al. 2009 [39] 370 0.52 0.43 to 0.61 −0.36 −0.46 to −0.25 Unblinded/opposite Negative
Streitberger and Kleinhenz 1998 [40] 60 0.8 0.65 to 0.95 −0.57 −0.77 to −0.36 Unblinded/opposite Positive
Streitberger et al. 2004 [41] 212 0.22 0.06 to 0.37 −0.25 −0.38 to −0.11 Unblinded/opposite Negative
Tong et al. 2010 [42] 63 1 NA −0.81 −1.06 to −0.56 Unblinded/opposite Positive
Tough et al. 2009 [43] 37 0.57 0.30 to 0.75 −0.67 −0.93 to −0.40 Unblinded/opposite Positive
Venzke et al. 2010 [44] 51 0.48 0.15 to 0.81 −0.42 −0.78 to −0.05 Unblinded/opposite Negative
White et al. 1996 [45] 9 1 NA −0.6 −1.30 to 0.10 Unblinded/opposite Negative
White et al. 2000 [46] 44 0.61 0.35 to 0.87 −0.26 −0.56 to 0.04 Unblinded/opposite Negative
White et al. 2007 [47] 37 0.77 0.55 to 0.98 −0.29 −0.61 to 0.03 Unblinded/opposite Positive
Alecrim-Andrade et al. 2008 [48] 36 0.26 0.14 to 0.39 −0.12 −0.23 to −0.00 Unblinded/random Negative
Harris et al. 2005 [49] 76 0.25 −0.09 to 0.59 −0.13 −0.50 to 0.23 Unblinded/random Negative
Lao et al. 1999 [50] 39 0.47 0.17 to 0.78 0.05 −0.21 to 0.31 Unblinded/random Positive
Linde et al. 2005 [51] 201 0.5 0.38 to 0.63 −0.06 −0.26 to 0.15 Unblinded/random Negative
Nabeta and Kawakita 2002 [52] 34 0.41 0.01 to 0.81 −0.18 −0.61 to 0.26 Unblinded/random Positive
Shen and Goddard 2007 [53] 15 0.78 0.37 to 1.19 0 −0.80 to 0.80 Unblinded/random Positive
Streitberger et al. 2008 [54] 20 0.55 0.29 to 0.81 −0.15 0.46 to 0.16 Unblinded/random Positive
Takakura and Yajima 2007 [55] 60 0.6 0.40 to 0.80 0.17 −0.08 to 0.42 Unblinded/random Positive
Takakura and Yajima 2008 [56] 114 0.37 0.20 to 0.54 −0.12 −0.30 to 0.06 Unblinded/random Positive
Tan et al. 2009 [57] 20 0.25 0.04 to 0.46 0.1 −0.12 to 0.32 Unblinded/random Positive
Tsukayama et al. 2006 BL23 [58] 20 0.4 −0.00 to 0.80 0 −0.44 to 0.44 Unblinded/random Negative
Wasan et al. 2010 [59] 40 0.8 0.61 to 0.99 0 −0.31 to 0.31 Unblinded/random Negative
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Table 3: Continued.
Study 𝑁 VBI VBI 95% CI SBI SBI 95% CI Scenario Study outcome
Chae et al. 2011 [60] 28 0.57 0.14 to 1.00 0.71 0.35 to 1.08 Unblinded/unblinded Positive
Kreiner et al. 2010 [61] 32 0.34 0.11 to 0.57 0.44 0.22 to 0.66 Unblinded/unblinded Positive
Tsukayama et al. 2006 L14 [58] 20 1 NA 0.3 −0.12 to 0.72 Unblinded/unblinded Negative
Wayne et al. 2008 [62] 14 0.22 −0.19 to 0.63 0.4 −0.30 to 1.10 Unblinded/unblinded Positive
Of the 54 studies, 22 studies used a commercially devel-
oped sham control device, 14 studies used a custom-made
sham control device, 12 used penetrating sham control, and 6
used a toothpick or cocktail stick. According to their averaged
blinding index scenarios, all of the sham control devices with
the exception of custom devices seemed to be effective in
blinding the subjects, with the penetrating sham controls
providing relatively more effective blinding.
In looking at the penetrating versus nonpenetrat-
ing dichotomy in a more direct way, the nonpenetrat-
ing group was unblinded/opposite, the mixed penetrat-
ing/nonpenetrating group was unblinded/opposite, and the
penetrating group was random/random. All of these scenar-
ios indicated effective blinding.
Studies with a greater number of subjects had a greater
unblinding in the verum group. Measurements assessed later
tended to have more ideal effectiveness of blinding than
measurements assessed immediately. Interestingly, there was
a higher tendency in both arms, when only the subjects—
not staff—were blinded, to believe they received the verum
treatment. The deqi group had slightly better EOB than the
insertion/puncture group, and the symptomatic group had
more ideal EOB than the healthy group.
Twenty-four studies used acupuncture-naı̈ve subjects,
and 19 used subjects with prior acupuncture experience.
Eleven of the studies were excluded from this section of the
review due to unknownprior experience ormixed experience
of the subjects. According to their averaged blinding index
scenarios, both groups were unblinded/random.
4. Discussion
This systematic review of 54 randomized controlled acupunc-
ture studies showed that overall 61% of the studies (as
a conservative estimate) meeting our inclusion/exclusion
criteria were effectively blinded. The most common scenario
encountered was unblinded in the acupuncture group and
opposite guess in the sham acupuncture group, which could
be indeed interpreted as “well-blinded.” In this scenario there
may be a psychological phenomenon of “wishful thinking.”
A majority of people, in both the verum and sham groups,
guessed that they received real acupuncture. Thus, guesses
are inflated towards real acupuncture in both study arms. It
is also possible that once a needle is administered, a subject
believes it is real acupuncture, or subjects may not knowwhat
to expect, creating a similar trend, or there is a strong placebo
effect.
A similar pattern emerges when looking at the V and S
groups individually; the averageVBIwas “unblinded” and the
average SBI was “opposite.” Is it possible for one not to know
when a needle is penetrating his or her skin? Perhaps the
answer is “no,” given that unblindedVmaymean that subjects
knowwhen their skin is being penetrated by a needle and thus
increases the chance a subject chooses the V acupuncture
group over the S acupuncture group upon questioning. Is it
possible for one to know when a needle is not penetrating
their skin? The answer seems to be “no” again; opposite
guesses in S may indicate that subjects are not able to tell if
they are not being penetrated by a needle, and thus are truly
guessing.
Most sham control devices with the exception of custom
devices were effective in blinding the subjects (Table 2).
Since there was a great diversity within the custom sham
group a more in depth case by case analysis of each device
could be performed, but at this time there does not seem
to be compelling evidence supporting the use of custom
sham devices. Even though commercial sham devices and
toothpick/cocktail stick devices appear to provide effective
blinding, the penetrating sham controls provided relatively
more effective blinding.
By comparing study blinding and study outcomes, the
majority of studies reported positive outcomes, regardless of
the degree of guess correctness. This leads us to believe that
there is no obvious association between EOB and reported
study outcomes. The current literature provides conflicting
evidence so the direction of bias may be specific to context
or treatment [6–9, 14–49, 51–62] or random.
Exploration of individual variables and their possible
effect on EOB indicated that some design characteristics
such as larger sample size, symptomatic subjects, and later
assessment were associated with more effective blinding,
and these may be encouraged to be further evaluated and
considered in designing future acupuncture trials.
4.1. Recommendations for Future Acupuncture Research. The
effect size was not a part of the extracted information
from the reviewed studies. This poses an interesting idea
for future investigation. Additional future research should
include a sufficiently powered, prospective randomized trial
comparing the EOB of different methods and sham devices
by direct comparison, as well as investigating the influence of
practitioner behavior, the patient’s expectations and beliefs,
and the location of treatment points on blinding effectiveness.
A good treatment should have a greater treatment effect
Evidence-Based Complementary and Alternative Medicine 7






















Shen and Goddard 2007
[53] 15 Staff + subject 0 NO C NP Chronic TM pain Unknown
Itoh et al. 2006 [30] 19 Staff + subject 21 NO C NP Chronic LBP Unknown
Nabeta and Kawakita
2002 [52] 34 Subject 28 NO C NP
Chronic neck and
shoulder pain Unknown
Tough et al. 2009 [43] 37 Subject 14 NO C NP Whiplash Unknown
Fink et al. 2001 [27] 64 Staff + subject 14 NO C NP Tension headache Unknown
Shen et al. 2009 [36] 12 Staff + subject 0 YES C NP Chronic myofacialpain of jaw muscles >365
Kreiner et al. 2010 [61] 32 Staff + subject 0 NO C NP Normal >365
Lao et al. 1999 [50] 39 Staff + subject 0.2 YES C NP After oral surgeryPain >365
Goddard et al. 2005 [28] 49 Subject 0 YES C NP Normal >365
Jubb et al. 2008 [22] 51 Subject 63 YES C NP Knee OA >365
Itoh et al. 2008 [31] 24 Staff + subject 35 NO C NP Knee OA 180
Deng et al. 2008 [16] 53 Subject 30 NO C NP After thoracotomyPain 42
Takakura and Yajima
2007 [55] 60 Staff + subject 0 NO C NP Normal 0
Takakura and Yajima
2008 [56] 114 Staff + subject 0 YES C NP Normal 0
Smith et al. 2007 [38] 27 Staff + subject 28 NO P NP TMJ Unknown
Tan et al. 2009 [57] 20 Subject 0 NO P NP Normal >365
Kennedy et al. 2008 [9] 45 Subject 42 NO P NP Acute LBP >365
Park et al. 2002 [34] 58 Staff + subject 84 NO P NP Acute stroke >365
Park et al. 2005 [35] 94 Staff + subject 14 NO P NP Stroke >365
Enblom et al. 2011 [26] 190 Staff + subject 35 NO P NP Radiation-inducednausea 365
Tsukayama et al. 2006
BL23 [58] 20 Staff + subject 0 NO P NP Normal 0
Tsukayama et al. 2006
L14 [58] 20 Staff + subject 0 NO P NP Normal 0
Chae et al. 2011 [60] 28 Subject 0 NO P NP Normal 0
Shin et al. 2010 [19] 42 Staff + subject 21 YES PEN P Dry eye Unknown
Tong et al. 2010 [42] 63 Subject 15 YES PEN P DPN ∼50%
Zaslawski et al. 1997 [20] 64 Subject 28 YES PEN P Stress ∼50%
Harris et al. 2005 [49] 76 Staff + subject 21 NO PEN P Fibromyaligia >365
Haake et al. 2007 [8] 692 Staff + subject 168 NO PEN P Chronic LBP >365
Linde et al. 2005 [51] 201 Staff + subject 168 YES PEN P Migraine HA 365
Brinkhaus et al. 2006
[25] 205 Subject 56 YES PEN P Chronic LBP 365
Endres et al. 2007 [17] 403 Staff + subject 180 YES PEN P Tension headache 365
Alecrim-Andrade et al.
2006 [23] 24 Staff + subject 84 YES PEN P Migraine HA 84
Alecrim-Andrade et al.
2008 [48] 36 Subject 84 YES PEN P Migraine HA 84























Lee et al. 2011 [33] 35 Staff + subject 70 NO PEN P Chronic pelvicpain 42
Lee et al. 2008 [32] 89 Subject 70 NO PEN P Chronic prostatitis 42
White et al. 2007 [47] 37 Subject 0 YES S NP ChronicPain/Normal Unknown
So et al. 2009 [39] 370 Staff + subject 0 NO S NP Infertility Unknown
Wayne et al. 2008 [62] 14 Staff + subject 28 NO S NP Endometriosis >365
Streitberger et al. 2008
[54] 20 Subject 0 NO S NP Normal >365
Wasan et al. 2010 [59] 40 Subject 0 YES S NP Chronic LBP >365
Barlas et al. 2006 [6] 48 Staff + subject 0 YES S NP Normal >365
Streitberger and
Kleinhenz 1998 [40] 60 Subject 0 NO S NP Normal >365
Enblom et al. 2008 [7] 80 Subject 0 NO S NP Normal >365
Kaptchuk et al. 2008 [15] 148 Staff + subject 42 NO S NP IBS >365
Goldman et al. 2008 [29] 118 Staff + subject 28 YES S NP Arm pain 365
Venzke et al. 2010 [44] 51 Subject 168 YES S NP Hot flashes 180
Streitberger et al. 2004
[41] 212 Staff + subject 1 YES S NP
postoperative
nausea 180
Deng et al. 2007 [21] 67 Subject 42 YES S NP Hot flashes 42
White et al. 1996 [45] 9 Staff + subject 42 NO T NP Tension headache >365
Harris et al. 2009 [18] 20 Staff + subject 0 NO T NP Fibromyalgia >365
White et al. 2000 [46] 44 Staff + subject 7 YES T NP Tension headache >365
Sherman et al. 2002 [37] 52 Subject 0 NO T NP Chronic LBP >365
Assefi et al. 2005 [14] 75 Staff + subject 84 NO T NP, P Fibromyalgia >365
Berman et al. 2004 [24] 283 Subject 182 YES T NP, P Knee OA >365
Sham devices: C: custom sham, P: park sham, PEN: penetrating sham, S: streitberger sham, and T: toothpick.
than placebo effect. It is important that we collect more
data in this field, especially qualitative data (e.g., reasons of
guessing in a particular way). It is possible that the reasons
for correct guesses in individual trials may be more revealing
than our numbers. Individual trialists should be willing to
share their experiences with others, as individual trialists and
patients must have greater insight and more stories to tell in
specific conditions within the trial than meta-analysis and
readers. This is particularly important, because any analysis
of available numeric data on blinding is destined to be prone
to some biases.
4.2. Systematic Review Limitations. There are several poten-
tial weaknesses of this review that we recognize. Language
bias may be a possibility given that we included only English
language publications while acupuncture is a popular treat-
ment modality in Asia and Europe. There is also a possibility
of publication bias, which is an inherent problem in virtually
all systematic reviews or meta-analyses. Moreover, it is
possible that some investigators collected blinding data, saw
the data, and decided not to report it in the paper, particularly
when blinding was shown to be unsatisfactory. Also, for
classification and decision making purposes, we used cate-
gorization/dichotomization (e.g., numerical BI cutoff of 0.2)
and summary statistics (e.g., average BI). Alternative ways of
analyzing the data could yield different results. Finally, in this
systematic review, we used the conventional terms commonly
used in the literature and equated “unblinded” with “correctly
guessed,” whereas there could be other reasons for correct
guesses.With its limitations, to our knowledge, this is the first
systematic review based on empirical blinding data.
In conclusion, based on the status of blinding, the most
common scenario encountered was a more correct guess in
the real acupuncture group and an opposite guess in the sham
acupuncture group, and the overall subject blinding of the
evaluated acupuncture studies was satisfactory. In addition,
quantitatively calculated blinding data, ideally together with
more qualitative data for individual trials, may offer mean-
ingful means to further interpret the findings of RCTs and
improve the practice in the direction of a higher validity.













































































































































































































































































































































































































































































































































































































































































































Figure 2: (a) Verum and (b) sham. Blinding index values with 95% confidence intervals. ∗Individual blinding index estimate and confidence
intervals raw data are provided in Table 3. Confidence intervals are unadjusted for multiple comparisons.
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